MyFinsight
Home
Blog
About
Proceeds from sales of
common stock
$272,000
(-74.95%↓ Y/Y)
Proceeds from borrowings
on notes payable -...
$44,944
(-55.06%↓ Y/Y)
Net cash provided by
financing activities
$316,944
(-91.11%↓ Y/Y)
End of period
$56,438
(63.33%↑ Y/Y)
Canceled cashflow
$260,506
Accounts payable and
accrued liabilities
$359,935
(-16.39%↓ Y/Y)
Amortization of intangible
assets
$279,891
Deposit/contract liability
$275,000
Issuance of common stock
for services
$80,000
(-98.44%↓ Y/Y)
Due from related
party
-$20,056
Operating lease right of
use asset
$14,815
(-53.45%↓ Y/Y)
Amortization of license
agreement
$14,683
(-97.89%↓ Y/Y)
Options vested for
stock-based compensation
$12,417
(-87.82%↓ Y/Y)
Accrued liabilities -
related parties
$6,000
(-80.00%↓ Y/Y)
Payroll tax liabilities
$3,337
(12.24%↑ Y/Y)
Prepaid
expenses-Nonrelated Party
-$855
Depreciation
$252
(-49.80%↓ Y/Y)
Net cash used in
operating activities
-$260,506
(92.62%↑ Y/Y)
Canceled cashflow
$1,067,241
Net loss
-$1,312,931
(87.20%↑ Y/Y)
Operating lease right of
use liabilities
-$14,816
(57.48%↑ Y/Y)
Back
Back
Cash Flow
MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC. (MGRX)
source: myfinsight.com